Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block
NCT02512471Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- May 2015
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in surgical anesthesia (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Minimum Effective Volume of Ropivacaine up to 6 months. Started May 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
surgical anesthesia
Beyond the preview
Go deeper on NCT02512471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512471.